Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma

Purpose: Immune checkpoint inhibitors are effective therapies for advanced hepatocellular carcinoma (HCC); however, comparisons of the clinical efficacy and safety profile for these drugs are still scarce. Thus, the aims of this study were to investigate the differences in efficacy and safety betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Hsin-Yu, Han, Meng-Zhi, Liao, Chih-Hsiang, Lin, Yih-Jyh, Wang, Chung-Teng, Chen, Shang-Hung, Chang, Ting-Tsung, Chen, Po-Jun, Lin, Sheng-Hsiang, Chen, Chiung-Yu, Chuang, Chiao-Hsiung, Wu, I-Chin, Wu, Juei-Seng, Hong, Tzu-Chun, Hsieh, Ming-Tsung, Lee, Yang-Cheng, Wu, Hung-Tsung, Tsai, Hong-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697961/
https://www.ncbi.nlm.nih.gov/pubmed/36365082
http://dx.doi.org/10.3390/pharmaceutics14112263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697961/
https://www.ncbi.nlm.nih.gov/pubmed/36365082
http://dx.doi.org/10.3390/pharmaceutics14112263

Ejemplares similares